Paul W. Shabram
Chief Tech/Sci/R&D Officer at BIORA THERAPEUTICS, INC.
Profile
Paul W.
Shabram is the founder of Ventana Biosciences, Inc. He is currently the Senior Vice President-Technical Operations at Biora Therapeutics, Inc. He previously worked as Vice President-Operations at Emergent Travel Health, Inc. and Vice President-Technical Development at Emergent BioSolutions, Inc. Shabram completed his undergraduate degree at the University of California, Santa Cruz and earned an MBA from the University of Phoenix.
Paul W. Shabram active positions
Companies | Position | Start |
---|---|---|
BIORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 25/04/2022 |
Former positions of Paul W. Shabram
Companies | Position | End |
---|---|---|
EMERGENT BIOSOLUTIONS INC. | Chief Tech/Sci/R&D Officer | - |
Ventana Biosciences, Inc. | Founder | - |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Paul W. Shabram
University of California, Santa Cruz | Undergraduate Degree |
University of Phoenix | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EMERGENT BIOSOLUTIONS INC. | Health Technology |
BIORA THERAPEUTICS, INC. | Health Services |
Private companies | 2 |
---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Ventana Biosciences, Inc. |
- Stock Market
- Insiders
- Paul W. Shabram